143 related articles for article (PubMed ID: 31271876)
21. Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions.
Guo M; Wang K; Hamill N; Lorimer K; Li M
Mol Pharm; 2016 Sep; 13(9):3292-307. PubMed ID: 27494289
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.
Bevernage J; Brouwers J; Brewster ME; Augustijns P
Int J Pharm; 2013 Aug; 453(1):25-35. PubMed ID: 23194883
[TBL] [Abstract][Full Text] [Related]
23. Insights into the mechanism of concomitant nucleation of form II and ethanol solvate of spironolactone in cooling crystallization.
Jia L; Yin Q; Zhou L; Zhang X; Wang C; Du W; Zhou L
RSC Adv; 2018 Mar; 8(18):9697-9706. PubMed ID: 35540856
[TBL] [Abstract][Full Text] [Related]
24. Impact of Physicochemical Properties of Cellulosic Polymers on Supersaturation Maintenance in Aqueous Drug Solutions.
Hong S; Nowak SA; Wah CL
AAPS PharmSciTech; 2018 May; 19(4):1860-1868. PubMed ID: 29637498
[TBL] [Abstract][Full Text] [Related]
25. Explicating the molecular level drug-polymer interactions at the interface of supersaturated solution of the model drug: Albendazole.
Joshi P; Mallepogu P; Kaur H; Singh R; Sodhi I; Samal SK; Jena KC; Sangamwar AT
Eur J Pharm Sci; 2021 Dec; 167():106014. PubMed ID: 34644598
[TBL] [Abstract][Full Text] [Related]
26. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
27. A study of hydrophobic domain formation of polymeric drug precipitation inhibitors in aqueous solution.
Zeneli E; Lange JJ; Holm R; Kuentz M
Eur J Pharm Sci; 2024 Jul; 198():106791. PubMed ID: 38705420
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis.
Warren DB; Bergström CA; Benameur H; Porter CJ; Pouton CW
Mol Pharm; 2013 Aug; 10(8):2823-48. PubMed ID: 23631696
[TBL] [Abstract][Full Text] [Related]
29. Supersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stability.
Ilie AR; Griffin BT; Kolakovic R; Vertzoni M; Kuentz M; Holm R
Drug Dev Ind Pharm; 2020 Mar; 46(3):356-364. PubMed ID: 31975613
[No Abstract] [Full Text] [Related]
30. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
Patel DD; Joguparthi V; Wang Z; Anderson BD
J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight.
Vora C; Patadia R; Mittal K; Mashru R
Pharm Dev Technol; 2016 Nov; 21(7):847-855. PubMed ID: 26333427
[TBL] [Abstract][Full Text] [Related]
32. Insights into the Role of Compendial/Biorelevant Media on the Supersaturation Behaviour of Drug Combination (Drug-Drug Interaction) and Precipitation Inhibition by Polymers.
Joshi P; Sangamwar AT
AAPS PharmSciTech; 2022 Nov; 23(8):300. PubMed ID: 36380100
[TBL] [Abstract][Full Text] [Related]
33. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
Madsen CM; Boyd B; Rades T; Müllertz A
Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
[TBL] [Abstract][Full Text] [Related]
34. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
35. Study of granule growth kinetics during in situ fluid bed melt granulation using in-line FBRM and SFT probes.
Kukec S; Hudovornik G; Dreu R; Vrečer F
Drug Dev Ind Pharm; 2014 Jul; 40(7):952-9. PubMed ID: 23662716
[TBL] [Abstract][Full Text] [Related]
36. Quality-by-design: an integrated process analytical technology approach to determine the nucleation and growth mechanisms during a dynamic pharmaceutical coprecipitation process.
Wu H; Khan MA
J Pharm Sci; 2011 May; 100(5):1969-86. PubMed ID: 21374627
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of FBRM as process analytical technology tool for dewatering processes via CST correlation.
Cobbledick J; Nguyen A; Latulippe DR
Water Res; 2014 Jul; 58():132-40. PubMed ID: 24751547
[TBL] [Abstract][Full Text] [Related]
38. Study growth kinetics in fluidized bed granulation with at-line FBRM.
Hu X; Cunningham JC; Winstead D
Int J Pharm; 2008 Jan; 347(1-2):54-61. PubMed ID: 17689213
[TBL] [Abstract][Full Text] [Related]
39. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
Stillhart C; Cavegn M; Kuentz M
J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
[TBL] [Abstract][Full Text] [Related]
40. Hot-melt extrusion for enhanced delivery of drug particles.
Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
